Oral Lichen Planus: Current Evidence, Clinical Challenges, and the Search for Optimal Management

Oral lichen planus (OLP) is a chronic, immune-mediated inflammatory disease of the oral mucosa with an incompletely understood etiology and a diverse clinical presentation. Because OLP is often refractory and follows a chronic or relapsing course, accurate diagnosis and appropriate long-term management remain important clinical challenges. The diagnosis of OLP is based on clinical findings and histopathological examination, with consideration of a variety of conditions that may mimic OLP, including oral lichenoid lesions, autoimmune blistering diseases, candidiasis, and leukoplakia. Management is primarily aimed at controlling inflammation and alleviating symptoms. Elimination of precipitating or aggravating factors, improvement of oral hygiene, and appropriate dental treatment are important components of long-term disease management. Topical corticosteroids remain the mainstay of local therapy, while topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, may provide useful alternatives, particularly in steroid-refractory cases. Laser therapy may also be considered as an adjunctive treatment in selected patients. Systemic corticosteroids are generally reserved for severe, extensive, or refractory disease. In addition, various adjunctive and alternative therapies, including herbal medicines, phytochemicals, vitamins, micronutrients, hydroxychloroquine, and methotrexate, have been investigated. Although several of these approaches have shown promising therapeutic effects, the available evidence remains limited and further high-quality clinical studies are required. OLP is currently classified among the oral potentially malignant disorders, although the magnitude of its malignant transformation risk remains debated. Therefore, long-term surveillance is important because some patients may develop oral squamous cell carcinoma. At present, the management of OLP focuses primarily on symptom relief and disease control rather than cure. A comprehensive and individualized approach that integrates accurate diagnosis, elimination of aggravating factors, oral health management, appropriate selection of topical and systemic therapies, and long-term surveillance is therefore important. Further clarification of the underlying mechanisms of OLP and well-designed clinical studies may contribute to more effective and individualized approaches to its diagnosis and management.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-10-15
DOI
https://doi.org/10.3390/jcm15207995
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oral Lichen Planus: Current Evidence, Clinical Challenges, and the Search for Optimal Management

Masanobu Abe
Journal of Clinical Medicine
Oral Health Pathology and Treatment
article

Oral Lichen Planus: Current Evidence, Clinical Challenges, and the Search for Optimal Management

Masanobu Abe
article en

Abstract

Oral lichen planus (OLP) is a chronic, immune-mediated inflammatory disease of the oral mucosa with an incompletely understood etiology and a diverse clinical presentation. Because OLP is often refractory and follows a chronic or relapsing course, accurate diagnosis and appropriate long-term management remain important clinical challenges. The diagnosis of OLP is based on clinical findings and histopathological examination, with consideration of a variety of conditions that may mimic OLP, including oral lichenoid lesions, autoimmune blistering diseases, candidiasis, and leukoplakia. Management is primarily aimed at controlling inflammation and alleviating symptoms. Elimination of precipitating or aggravating factors, improvement of oral hygiene, and appropriate dental treatment are important components of long-term disease management. Topical corticosteroids remain the mainstay of local therapy, while topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, may provide useful alternatives, particularly in steroid-refractory cases. Laser therapy may also be considered as an adjunctive treatment in selected patients. Systemic corticosteroids are generally reserved for severe, extensive, or refractory disease. In addition, various adjunctive and alternative therapies, including herbal medicines, phytochemicals, vitamins, micronutrients, hydroxychloroquine, and methotrexate, have been investigated. Although several of these approaches have shown promising therapeutic effects, the available evidence remains limited and further high-quality clinical studies are required. OLP is currently classified among the oral potentially malignant disorders, although the magnitude of its malignant transformation risk remains debated. Therefore, long-term surveillance is important because some patients may develop oral squamous cell carcinoma. At present, the management of OLP focuses primarily on symptom relief and disease control rather than cure. A comprehensive and individualized approach that integrates accurate diagnosis, elimination of aggravating factors, oral health management, appropriate selection of topical and systemic therapies, and long-term surveillance is therefore important. Further clarification of the underlying mechanisms of OLP and well-designed clinical studies may contribute to more effective and individualized approaches to its diagnosis and management.

Journal of Clinical MedicineVol. 15(20)
Japanese Foundation For Cancer Research (JP)
Good health and well-being
Openalex Percentile: Top 11%
Oral Health Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.